BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17971513)

  • 1. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
    Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human GIP(3-30)NH
    Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
    Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
    Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
    J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
    Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
    J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF1 links GIPR signaling to the control of beta cell function and survival.
    Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
    Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
    Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ
    Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
    Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
    Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
    Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.
    Maekawa R; Ogata H; Murase M; Harada N; Suzuki K; Joo E; Sankoda A; Iida A; Izumoto T; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Arima H; Hayashi Y; Seino Y
    Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E572-E583. PubMed ID: 29406782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant.
    Yammine L; Picatoste B; Abdullah N; Leahey RA; Johnson EF; Gómez-Banoy N; Rosselot C; Wen J; Hossain T; Goncalves MD; Lo JC; Garcia-Ocaña A; McGraw TE
    Mol Metab; 2023 Dec; 78():101831. PubMed ID: 37925022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Fat Diet During Mouse Pregnancy and Lactation Targets GIP-Regulated Metabolic Pathways in Adult Male Offspring.
    Kruse M; Keyhani-Nejad F; Isken F; Nitz B; Kretschmer A; Reischl E; de las Heras Gala T; Osterhoff MA; Grallert H; Pfeiffer AF
    Diabetes; 2016 Mar; 65(3):574-84. PubMed ID: 26631738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling.
    Tseng CC; Zhang XY
    Endocrinology; 2000 Mar; 141(3):947-52. PubMed ID: 10698169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
    Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
    Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions.
    Nasteska D; Harada N; Suzuki K; Yamane S; Hamasaki A; Joo E; Iwasaki K; Shibue K; Harada T; Inagaki N
    Diabetes; 2014 Jul; 63(7):2332-43. PubMed ID: 24584548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
    Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
    Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.
    Zhang Q; Delessa CT; Augustin R; Bakhti M; Colldén G; Drucker DJ; Feuchtinger A; Caceres CG; Grandl G; Harger A; Herzig S; Hofmann S; Holleman CL; Jastroch M; Keipert S; Kleinert M; Knerr PJ; Kulaj K; Legutko B; Lickert H; Liu X; Luippold G; Lutter D; Malogajski E; Medina MT; Mowery SA; Blutke A; Perez-Tilve D; Salinno C; Sehrer L; DiMarchi RD; Tschöp MH; Stemmer K; Finan B; Wolfrum C; Müller TD
    Cell Metab; 2021 Apr; 33(4):833-844.e5. PubMed ID: 33571454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
    Akindehin S; Liskiewicz A; Liskiewicz D; Bernecker M; Garcia-Caceres C; Drucker DJ; Finan B; Grandl G; Gutgesell R; Hofmann SM; Khalil A; Liu X; Cota P; Bakhti M; Czarnecki O; Bastidas-Ponce A; Lickert H; Kang L; Maity G; Novikoff A; Parlee S; Pathak E; Schriever SC; Sterr M; Ussar S; Zhang Q; DiMarchi R; Tschöp MH; Pfluger PT; Douros JD; Müller TD
    Mol Metab; 2024 May; 83():101915. PubMed ID: 38492844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.
    Lynn FC; Thompson SA; Pospisilik JA; Ehses JA; Hinke SA; Pamir N; McIntosh CH; Pederson RA
    FASEB J; 2003 Jan; 17(1):91-3. PubMed ID: 12475913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.